Deep Medicine Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DMAQ research report →
About the company
Deep Medicine Acquisition Corp. (DMAQ) currently operates as a non-operating entity, possessing no substantial business functions of its own. Its express purpose is to execute a business combination, which could entail a merger, an acquisition of equity or assets, or a reorganization, with one or more target companies.
- CEO
- Humphrey P. Polanen
- IPO
- 2021
- Employees
- 2
- HQ
- New York City, NY, US
Price Chart
- Market Cap
- $12.90M
- P/E
- -0.03
- P/S
- 0.04
- P/B
- 0.28
- EV/EBITDA
- 0.26
- Div Yield
- 0.00%
- Gross Margin
- 46.13%
- Op Margin
- -33.29%
- Net Margin
- -75.66%
- ROE
- -322.33%
- ROIC
- -66.61%
- Revenue
- $18.88M · -13.63%
- Net Income
- $-15,227,893 · -73.13%
- EPS
- $-51.39 · 93.20%
- Op Income
- $-6,102,354
- FCF YoY
- 52.78%
- 52W High
- $19.91
- 52W Low
- $2.96
- 50D MA
- $10.77
- 200D MA
- $11.23
- Beta
- 0.02
- Avg Volume
- 14.21K
Get TickerSpark's AI analysis on DMAQ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 31, 23 | Bright Vision Sponsor LLC | other | 150,000 |
| Oct 15, 22 | Chiang John | other | 0 |
| Oct 15, 22 | Chiang John | other | 0 |
| Oct 26, 21 | POLANEN HUMPHREY P | other | 0 |
| Oct 29, 21 | Bright Vision Sponsor LLC | other | 406,500 |
| Oct 26, 21 | LUO WEIXUAN | other | 0 |
| Oct 26, 21 | Miao Wanlei | other | 0 |
| Oct 26, 21 | Spires Tina | other | 0 |
| Oct 26, 21 | Bright Vision Sponsor LLC | other | 3,162,500 |
| Oct 26, 21 | Razmi Ronald M. | other | 0 |
Our DMAQ coverage
Recent articles, reports, and earnings notes.
No research on DMAQ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DMAQ report →Similar companies
Peers in the same neighborhood.